20 March 2024
Court of Justice of European Union Clarifies Impartiality Requirements for Experts Consulted by European Medicines Agency
1 min read
On 14 March 2024, the Court of Justice of the European Union held that the European Medicines Agency (EMA) had breached the impartiality requirements when examining a marketing authorisation for a medicinal product.
On 14 March 2024, the Court of Justice of the European Union held that the European Medicines Agency (EMA) had breached the impartiality requirements when examining a marketing authorisation for a medicinal product. The EMA was also found to have breached its own internal procedural guidelines. The judgment is noteworthy because it overturns an earlier judgment of the General Court which had dismissed the plaintiff’s action.
Please find attached a note discussing this judgment. A link to the judgment is included in the note.
Attachments:
->
News & insights
2 min
read
read
Briefings
Belgian Competition Authority Publishes Guidelines on Sustainability Agreements
7 April 2026
1 min
read
read
Briefings
Court of Justice of European Union Clarifies Scope of Officinal Formula Exemption Under EU Medicinal Product Law
25 March 2026
3 min
read
read
Briefings
UK CMA Concludes Veterinary Sector Market Investigation and Announces Major Reforms
24 March 2026
1 min
read
read
Briefings
European Commission publishes draft Industrial Accelerator Act: What to expect?
17 March 2026
1 min
read
read
Briefings
Belgian Competition Authority Investigates AutoScout24 Platform for Possible Abuse of Dominance
13 March 2026
2 min
read
read
Briefings
EU Pharmaceutical Package Moves Closer to Formal Adoption
6 March 2026
1 min
read
read
Briefings
EU General Court Annuls Anti-Circumvention Extension and rejects Commission’s Broad View of “Assembly Operations”
6 March 2026
